Skip to main content

Anne
E.
Burke
,
MD

Division Director, Family Planning, Gynecology and Obstetrics, JHMI
Associate Professor
Anne Burke

Departmental Affiliations

School of Medicine
Primary

Contact Info

Johns Hopkins Bayview Medical Center, 4940 Eastern Avenue
Baltimore
Maryland
21224
US        

Research Interests

Family planning; Clinical trials focused on contraception (new and existing contraceptive methods); Pain management during abortion; Contraceptive outcomes research; Women’s reproductive health
Experiences & Accomplishments
Education
MPH
Johns Hopkins Bloomberg School of Public Health
2002
MD
University of Pittsburgh
1996
Overview
2014-present Division Director, Family Planning, Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD
2008-present Fellowship Director, Family Planning, Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD

My primary research focus is family planning. Within this broad topic, my research has focused on two main areas: clinical trials focused on contraception (new and existing contraceptive methods) and pain management during abortion; and contraceptive outcomes research. I have been the site PI for clinical trials of several novel contraceptive methods. Research on contraceptive outcomes, such as among obese women and women post-pregnancy, has involved utilizing surveys and medical records. A current interest is contraceptives and health outcomes from a population health perspective, utilizing large claims and EMR datasets. Through ongoing and productive collaborations with colleagues, I am currently working on 2 such studies (externally funded), and have plans for a third. A large part of my research work involves mentorship of trainees as they conduct their own research studies, primarily fellows but also residents, medical students, and public health students.

While family planning is my primary focus, I remain interested in research questions relevant to women’s reproductive health from a broader perspective. I was a co-investigator on a cohort study of HPV and perimenopause, relevant to changing guidelines for Pap smear screening, and am working with colleagues on their study of the effects of contraception and pregnancy on the vaginal microbiome.
Honors & Awards
2007-17: Best Doctors
2001: Association of Reproductive Health Professionals (ARHP) Young Researcher Award
2001: Delta Omega, Public Health Honor Society, Alpha Chapter
Select Publications
Recent peer-reviewed publications
  • Jensen JT, Edelman AB, Chen BA, Archer DF, Barnhart KT, Thomas MA, Burke AE, Westhoff CL, Wan LS, Sitruk-Ware R, Kumar N, Variano B, Blithe DL. Continuous dosing of a novel contraceptive vaginal ring releasing Nestorone® and estradiol: pharmacokinetics from a dose-finding study. Contraception. 2018 May;97(5):422-427. doi: 10.1016/j.contraception.2018.01.012. Epub 2018 Feb 2.
  • Lee JK, Burke AE. Moreau CM. Female and male decision-making regarding whether to continue or abort an unintended pregnancy. European Journal of Contraception and Reproductive Health Care, 2018. doi: 10.1080/13625187.2018.1506100. Epub 2018 Sep 28. PMID: 30264595.
  • Mark K, Frost A, Hussey H, Lopez-Acevedo M, Burke AE, Edwardson J, Solaru O, Gravitt P. Rates of regression of cervical dysplasia between initial biopsy and excisional procedure in routine clinical practice. Arch Gynecol Obstet. 2019 Jan 4. doi: 10.1007/s00404-018-5026-8. [Epub ahead of print] PMID: 30607589
  • Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, Viscidi RP, Burke AE, Ravel J, Gravitt PE. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2018 Nov;25(11):1321-1330. doi: 10.1097/GME.0000000000001236
  • Onyewuchi UF, Tomaszewski K, Upadhya KK, Gupta PS, Whaley N, Burke AE, Trent ME. Improving LARC Access for Urban Adolescents and Young Adults in the Pediatric Primary Care Setting. Clin Pediatr (Phila). 2019 Jan;58(1):24-33. doi: 10.1177/0009922818805234. Epub 2018 Oct 13 PMID: 30318927
Projects
Bringing more evidence into contraceptive counseling: Building a new provider tool to tailor predictions of contraceptive outcomes to patient sub-populations